Filter
1884
Filtered Results: 1884
Text search:
Government
of
Nigeria
Featured
Recommendations
130
New Publications
510
Language
Document type
No document type
1024
Studies & Reports
503
Guidelines
119
Strategic & Response Plan
76
Manuals
67
Fact sheets
39
Training Material
26
Situation Updates
16
Resource Platforms
8
Infographics
3
Brochures
1
App
1
Online Courses
1
Countries / Regions
Nigeria
225
Global
131
Africa
99
Sierra Leone
64
Liberia
60
Kenya
48
Ethiopia
44
Congo, Democratic Republic of
41
Guinea
33
Uganda
33
West and Central Africa
33
Cameroon
30
Senegal
28
Malawi
26
Ghana
25
South Africa
24
Burkina Faso
21
East and Southern Africa
21
India
20
Tanzania
20
Rwanda
19
Benin
19
Mali
18
South Sudan
17
Zambia
17
Syria
16
Zimbabwe
15
Central African Republic
15
Niger
14
Mozambique
14
Yemen
12
Western and Central Europe
12
Afghanistan
11
Ukraine
11
Myanmar / Burma
11
Middle East and North Africa
11
Nepal
10
Namibia
10
Bangladesh
9
Côte d’Ivoire / Ivory Coast
8
Somalia
8
Pakistan
8
Indonesia
8
Latin America and the Carribbean
8
Chad
7
Asia
7
Cambodia
6
Colombia
6
Togo
5
Haiti
5
Gambia
5
China
5
Sudan
5
Eswatini/ Swaziland
5
South–East Asia Region
5
Guinea-Bissau
4
Philippines
4
Germany
4
Botswana
4
Angola
4
Venezuela
4
Russia
4
Mauritania
3
Libya
3
Lesotho
3
Mexico
3
Palestine
3
Gabon
3
Iraq
2
Jordan
2
Burundi
2
Poland
2
Eastern Europe
2
Southern Africa
2
Congo-Brazzaville
2
Romania
2
Moldova
2
Vietnam
2
Japan
2
Tunisia
2
Morocco
1
Lebanon
1
Egypt
1
Thailand
1
Malaysia
1
Argentina
1
Peru
1
Brazil
1
Serbia
1
Ecuador
1
Bolivia
1
Madagascar
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Italy
1
Armenia
1
Laos
1
Tajikistan
1
Estonia
1
Iran
1
Mauritius
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
581
Women & Child Health
139
Clinical Guidelines
108
Public Health
102
Key Resources
87
Capacity Building
28
Pharmacy & Technologies
9
Toolboxes
COVID-19
169
HIV
159
Mental Health
149
Ebola
103
Planetary Health
85
TB
84
Disability
72
Rapid Response
58
Global Health Education
58
AMR
54
Refugee
49
Health Financing Toolbox
48
Caregiver
46
NTDs
44
Conflict
40
Polio
35
Pharmacy
31
NCDs
29
Natural Hazards
10
Cholera
7
Specific Hazards
7
Social Ethics
5
Zika
2
Health Financing
1
Implementation guide for national, district and facility levels.
This implementation guide contains practical guidance for policy-makers,
programme managers, health practitioners and other actors working to
establish and implement quality of care...
This study emphasizes the contribution that women can play in the prevention of violent extremism within the family and society and analyzes the drivers and roles of women taking part in violent ext...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neuro...
Donor financing to low- and middle-income countries for reproductive, maternal, newborn, and child health increased substantially from 2008 to 2013. However, increased spending by donors might not improve outcomes, if funds are delivered in ways that undermine countries’ public financial managemen...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of<...
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence ... TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years are measured at the same time in any district being surveyed. This was the approach of the Global Trachoma Mapping Project, which undertook baseline surveys in > 1500 districts worldwide in order to provide the data required to start interventions where needed.
The survey design recommended by WHO is a two-stage cluster random sample survey, which uses probability proportional to size sampling to select 20–30 villages, and random, systematic or quasi-random sampling to select 25–30 households in each of those villages. In most surveys, everyone aged ≥ 1 year living in selected households is examined.
The survey design recommended by WHO is a two-stage cluster random sample survey, which uses probability proportional to size sampling to select 20–30 villages, and random, systematic or quasi-random sampling to select 25–30 households in each of those villages. In most surveys, everyone aged ≥ 1 year living in selected households is examined.
Kassa BMC Infectious Diseases (2018) 18:216 https://doi.org/10.1186/s12879-018-3126-5
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
...
The Fifty-first World Health Assembly adopted resolution WHA51.11 in 1998, which targets the
global elimination of trachoma as a public health problem by 2020 (1). The strategy recommended
to achieve that goal is encapsulated by the acronym “SAF...
As a high-burden neglected tropical disease, soil-transmitted helminth (STH) infections remain a major problem in the world, especially among children under five years of age. Since young children are at high risk ... being infected, STH infection can have a long-term negative impact on their life, including impaired growth and development. Stunting, a form of malnutrition in young children, has been long assumed as one of the risk factors in acquiring the STH infections. However, the studies on STH infection in children under five with stunting have been lacking, resulting in poor identification of the risk. Accordingly, we collected and reviewed existing related research articles to provide an overview of STH infection in a susceptible population of stunted children under five years of age in terms of prevalence and risk factors. There were 17 studies included in this review related to infection with Ascaris lumbricoides, Trichuris trichiura, hookworm, and Strongyloides stercoralis from various countries. The prevalence of STH infection in stunted children ranged from 12.5% to 56.5%. Increased inflammatory markers and intestinal microbiota dysbiosis might have increased the intensity of STH infection in stunted children that caused impairment in the immune system. While the age from 2 to 5 years along with poor hygiene and sanitation has shown to be the most common risk factors of STH infections in stunted children; currently there are no studies that show direct results of stunting as a risk factor for STH infection. While stunting itself may affect the pathogenesis of STH infection, further research on stunting as a risk factor for STH infection is encouraged.
An estimated 99% of children worldwide – or more than 2.3 billion children – live in one of the 186 countries that have implemented some form of...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment ... people infected with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
The agenda focuses on six critical changes necessary for more children suffering from SAM to access effective treatment. Building on lessons from the last decade, and the experiences of other successful health initiatives, the agenda addresses issue...
Interim Guidance.
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychoso...
A number of medical problems have been reported in survivors, including mental health issues. Ebola virus may persist in some body fluids, including semen. Ebola survivors need comprehensive support for the medical and psychoso...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss ... confidence in health professionals, manufacturers and distributors and in health systems. In an effort to protect people’s health, the WHO Regional Director for Africa, Dr Matshidiso Moeti, has proposed a strategy aimed at strengthening National Medicine Regulatory Authorities (NMRAs) in order to ensure that only safe, good quality and effective medical products are available.
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource...
